Anticonvulsants Market

Anticonvulsants Market by Products (Barbiturates, Aldehydes, Benzodiazepines, Aromatic Allylic Alcohols, Carboxamides, Bromides, Carbamates, Sulfonamides, Fructose Derivatives, Pyrrolidines, Triazines, Fatty Acids, Oxazolidinediones, Urea’s, GABA Analogs, Propionates, Hydantoins, Pyrimidinediones, Valproylamides, and Others), Applications (Epilepsy, Fibromyalgia, Migraine, Neuropathic Pain, Bipolar Disorder, Anxiety, and Borderline Personality Disorder), End-users (Hospitals, Clinics, and Ambulatory Surgical Clinics), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.

  • Report ID: HC-2374
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 180
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global anticonvulsants market size is estimated to expand at a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the high prevalence of patients across the world, increasing research of novel drugs, and rising awareness of the diseases around the globe.


Anticonvulsants Market Key Takeaways

Anticonvulsants drugs, also called as antiseizure or antiepileptic drugs, are types of medications used for the treatment based on symptoms of epileptic seizures. The epileptic seizures happen due to incorrect signal from the nerve cells to the brain or disturbance in the electrical activity of the brain, which results in recurring episodes. Epilepsy can occur to people of different age groups due to some of these factors such as drug abuse and alcohol misuse, brain cancer, brain injury, and stroke. The symptoms demonstrated by the patient before convulsions include nausea, strange feelings, visual loss, headache, numbness in the body parts, and the racing thoughts. Anticonvulsants drugs are also used as mood stabilizers as well as for the cure of neuropathic pain or bipolar disorders.

The anticonvulsant drugs work by controlling neuronal excitability through different molecular targets present at the synapse, such as glutamate receptors, voltage-gated ion channels, and voltage-gated GABA receptors. Orthodox antiepileptic drugs augment γ-aminobutyric acid (GABA) function or blocks sodium channels. Various antiepileptic drugs work on different or uncertain mechanisms of the action. Some of the main anticonvulsant drugs in the market which are also used for pain management include depakote (divalproex), lyrica (pregabalin), topamax (topiramate), neurontin (gabapentin), and carbatrol/tegretol (carbamazepine).

Market Trends, Drivers, Restraints, and Opportunities

  • High prevalence of epilepsy as well as rising awareness for the prevention of the disease among the population are driving the market in the coming future.
  • Growing research & development activities for the advanced development in the epilepsy therapeutics is expected to propel the market expansion during the projected period.
  • Inclining number of new drug approvals and favorable regulatory policies towards the development of new drugs are boosting the market. The perampanel and retigabine are newly approved antiepileptics.
  • Increasing number of patent expiry of major drugs brand such as Lamictal is anticipated to restrict the market growth.
  • Growing interest from government organizations providing information about disease management and spreading awareness of the disease are offering huge opportunities for market development.

Scope of the Report

The report on the global anticonvulsants market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Anticonvulsants Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Barbiturates, Aldehydes, Benzodiazepines, Aromatic Allylic Alcohols, Carboxamides, Bromides, Carbamates, Sulfonamides, Fructose Derivatives, Pyrrolidines, Triazines, Fatty Acids, Oxazolidinediones, Urea’s, GABA Analogs, Propionates, Hydantoins, Pyrimidinediones, Valproylamides, and Others), Applications (Epilepsy, Fibromyalgia, Migraine, Neuropathic Pain, Bipolar Disorder, Anxiety, and Borderline Personality Disorder), and End-users (Hospitals, Clinics, and Ambulatory Surgical Clinics)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

GlaxoSmithKline, Johnson & Johnson, Sanofi, Pfizer, Novartis, Abbott, Sunovion Pharmaceuticals, and Cephalon

Market Segment Insights

Barbiturates segment is expected to grow at a rapid pace

Based on products, the global anticonvulsants market is divided into barbiturates, aldehydes, triazines, benzodiazepines, aromatic allylic alcohols, bromides, carbamates, sulfonamides, pyrimidinediones, carboxamides, pyrrolidines, fatty acids, oxazolidinediones, urea’s, gaba analogs, propionates, fructose derivatives, hydantoins, valproylamides, and others. The barbiturates segment is expected to grow at a rapid pace during the projected period owing to its high effectiveness and safety along with better tolerability. It is the first choice drug for the epilepsy patients and shows good effects against epilepsy.

The hydantoins segment, meanwhile, is anticipated to account for a considerable market share in the near future as they are modern anticonvulsants drugs and offer safety. Thus, the drugs are widely recommended by the healthcare professionals, which further boosts the segment growth.

Epilepsy segment is projected to expand at a considerable CAGR

On the basis of applications, the market is categorized as epilepsy, fibromyalgia, migraine, neuropathic pain, bipolar disorder, anxiety, and borderline personality disorder. The epilepsy segment is projected to expand at a considerable CAGR during the forecast period owing to the large number of incidence of the disease and growing demand for effective drugs for the treatment from the patients. Additionally, increased awareness about the disease and development of novel drugs are boosting the market segment.

However, the neuropathic pain segment is expected to exhibit a robust growth rate during the targeted period due to the rising number of patients suffering from the disease and wide availability of the drugs for the disease treatment.


Anticonvulsants Market By Applications

Clinics segment is anticipated to grow at a significant rate

Based on end-users, the global anticonvulsants market is segmented into hospitals, clinics, and ambulatory surgical clinics. The clinics segment is anticipated to grow at a significant rate in the coming years owing to large preference of patients towards clinics due to easy accessibility at low cost and expansion of specialized clinics for the particular disease treatment. The patients can visit the clinics easily and get consultation of the doctor without going through the long process that are associated with patients’ visiting at the hospitals. However, the hospitals segment is projected to exhibit lucrative growth during the forecast period as the patient with severe attack needs to find proper healthcare facility and high frequency of such patients visiting hospitals.

North America is anticipated to constitute a key market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the projected period due to the availability of high skilled healthcare professionals, extensive research activities, and high prevalence of epilepsy in the region.

The Asia Pacific market, on the other hand, is expected to propel at an impressive rate in the coming years due to the high number of targeted patients and rising number of patients who are awareness of the disease as well as treatment drugs. Moreover, several governments’ efforts in various countries for the disease management is anticipated to boost the regional market growth.


Anticonvulsants Market By Regions

Segments

Segments Covered in the Report
The global anticonvulsants market has been segmented on the basis of

Products
  • Barbiturates
  • Aldehydes
  • Benzodiazepines
  • Carboxamides
  • Bromides
Applications
  • Epilepsy
  • Fibromyalgia
  • Migraine
  • Neuropathic Pain
  • Bipolar Disorder
  • Anxiety
  • Borderline Personality Disorder
End-users
  • Hospitals
  • Clinics
  • Ambulatory Surgical Clinics
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • GlaxoSmithKline
  • Johnson & Johnson
  • Sanofi
  • Pfizer
  • Novartis
  • Abbott
  • Sunovion Pharmaceuticals
  • Cephalon

Competitive Landscape

Key players competing in the global anticonvulsant market are GlaxoSmithKline; Johnson & Johnson; Sanofi; Pfizer; Novartis; Abbott; Sunovion Pharmaceuticals; and Cephalon.

Anticonvulsants Market By Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Anticonvulsants Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Anticonvulsants Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Anticonvulsants Market - Supply Chain
  4.5. Global Anticonvulsants Market Forecast
     4.5.1. Anticonvulsants Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Anticonvulsants Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Anticonvulsants Market Absolute $ Opportunity
5. Global Anticonvulsants Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Anticonvulsants Market Size and Volume Forecast by Types
     5.3.1. Epilepsy Fibromyalgia Migraine Neuropathic Pain Bipolar Disorder Anxiety  
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Anticonvulsants Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Anticonvulsants Market Size and Volume Forecast by End Users
     6.3.1. Hospitals Clinics Ambulatory Surgical Clinics
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Anticonvulsants Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Anticonvulsants Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Anticonvulsants Demand Share Forecast, 2019-2026
8. North America Anticonvulsants Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Anticonvulsants Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Anticonvulsants Market Size and Volume Forecast by Types
     8.4.1. Epilepsy Fibromyalgia Migraine Neuropathic Pain Bipolar Disorder Anxiety  
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Anticonvulsants Market Size and Volume Forecast by End Users
     8.7.1. Hospitals Clinics Ambulatory Surgical Clinics
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Anticonvulsants Demand Share Forecast, 2019-2026
9. Latin America Anticonvulsants Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Anticonvulsants Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Anticonvulsants Market Size and Volume Forecast by Types
     9.4.1. Epilepsy Fibromyalgia Migraine Neuropathic Pain Bipolar Disorder Anxiety  
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Anticonvulsants Market Size and Volume Forecast by End Users
     9.7.1. Hospitals Clinics Ambulatory Surgical Clinics
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Anticonvulsants Demand Share Forecast, 2019-2026
10. Europe Anticonvulsants Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Anticonvulsants Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Anticonvulsants Market Size and Volume Forecast by Types
     10.4.1. Epilepsy Fibromyalgia Migraine Neuropathic Pain Bipolar Disorder Anxiety  
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Anticonvulsants Market Size and Volume Forecast by End Users
     10.7.1. Hospitals Clinics Ambulatory Surgical Clinics
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Anticonvulsants Demand Share Forecast, 2019-2026
11. Asia Pacific Anticonvulsants Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Anticonvulsants Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Anticonvulsants Market Size and Volume Forecast by Types
     11.4.1. Epilepsy Fibromyalgia Migraine Neuropathic Pain Bipolar Disorder Anxiety  
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Anticonvulsants Market Size and Volume Forecast by End Users
     11.7.1. Hospitals Clinics Ambulatory Surgical Clinics
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Anticonvulsants Demand Share Forecast, 2019-2026
12. Middle East & Africa Anticonvulsants Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Anticonvulsants Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Anticonvulsants Market Size and Volume Forecast by Types
     12.4.1. Epilepsy Fibromyalgia Migraine Neuropathic Pain Bipolar Disorder Anxiety  
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Anticonvulsants Market Size and Volume Forecast by End Users
     12.7.1. Hospitals Clinics Ambulatory Surgical Clinics
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Anticonvulsants Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Anticonvulsants Market: Market Share Analysis
  13.2. Anticonvulsants Distributors and Customers
  13.3. Anticonvulsants Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. GlaxoSmithKline Johnson & Johnson Sanofi Pfizer Novartis Abbott  
Segments Covered in the Report
The global anticonvulsants market has been segmented on the basis of

Products
  • Barbiturates
  • Aldehydes
  • Benzodiazepines
  • Carboxamides
  • Bromides
Applications
  • Epilepsy
  • Fibromyalgia
  • Migraine
  • Neuropathic Pain
  • Bipolar Disorder
  • Anxiety
  • Borderline Personality Disorder
End-users
  • Hospitals
  • Clinics
  • Ambulatory Surgical Clinics
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • GlaxoSmithKline
  • Johnson & Johnson
  • Sanofi
  • Pfizer
  • Novartis
  • Abbott
  • Sunovion Pharmaceuticals
  • Cephalon

Key players competing in the global anticonvulsant market are GlaxoSmithKline; Johnson & Johnson; Sanofi; Pfizer; Novartis; Abbott; Sunovion Pharmaceuticals; and Cephalon.

Anticonvulsants Market By Key Players

Buy Report